<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Estrella MM</submitter><funding>NICHD NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><pagination>217-20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3243740</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(2)</volume><pubmed_abstract>BACKGROUND:In the early highly active antiretroviral therapy (HAART) era, kidney dysfunction was strongly associated with death among HIV-infected individuals. We re-examined this association in the later HAART period to determine whether chronic kidney disease remains a predictor of death after HAART initiation. METHODS:To evaluate the effect of kidney function at the time of HAART initiation on time to all-cause mortality, we evaluated 1415 HIV-infected women initiating HAART in the Women's Interagency HIV Study. Multivariable proportional hazards models with survival times calculated from HAART initiation to death were constructed; participants were censored at the time of the last available visit or December 31, 2006. RESULTS:Chronic kidney disease (estimated glomerular filtration rate less than 60 mL/min/1.73 m) at HAART initiation was associated with higher mortality risk adjusting for age, race, hepatitis C serostatus, AIDS history, and CD4 cell count (hazard ratio 2.23, 95% confidence interval: 1.45-3.43). Adjustment for hypertension and diabetes history attenuated this association (hazard ratio = 1.89, confidence interval: 0.94-3.80). Lower kidney function at HAART initiation was weakly associated with increased mortality risk in women with prior AIDS (hazard ratio = 1.09, confidence interval: 1.00-1.19, per 20% decrease in estimated glomerular filtration rate). CONCLUSIONS:Kidney function at HAART initiation remains an independent predictor of death in HIV-infected individuals, especially in those with a history of AIDS. Our study emphasizes the necessity of monitoring kidney function in this population. Additional studies are needed to determine mechanisms underlying the increased mortality risk associated with chronic kidney disease in HIV-infected persons.</pubmed_abstract><journal>Journal of acquired immune deficiency syndromes (1999)</journal><pubmed_title>The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.</pubmed_title><pmcid>PMC3243740</pmcid><funding_grant_id>R01-DK-07677001</funding_grant_id><funding_grant_id>U01 DK070657</funding_grant_id><funding_grant_id>K23 DK081317-02</funding_grant_id><funding_grant_id>U01-AI-42590</funding_grant_id><funding_grant_id>U01 AI034994</funding_grant_id><funding_grant_id>U01 AI035004</funding_grant_id><funding_grant_id>U01 AI034993</funding_grant_id><funding_grant_id>1R01-DK-072367</funding_grant_id><funding_grant_id>R01 DK072367</funding_grant_id><funding_grant_id>K23 DK081317</funding_grant_id><funding_grant_id>U01-AI-31834</funding_grant_id><funding_grant_id>UL1 RR024131</funding_grant_id><funding_grant_id>R21 DK078218</funding_grant_id><funding_grant_id>U01 AI031834</funding_grant_id><funding_grant_id>U01 AI034989</funding_grant_id><funding_grant_id>5U01DK070657-03</funding_grant_id><funding_grant_id>1K23-DK-081317-01A1</funding_grant_id><funding_grant_id>U01 HD032632</funding_grant_id><funding_grant_id>R01 DK080094</funding_grant_id><funding_grant_id>U01-AI-34989,</funding_grant_id><funding_grant_id>R01-DK-080094-02</funding_grant_id><funding_grant_id>U01 AI042590</funding_grant_id><funding_grant_id>R21-DK078218-01A1</funding_grant_id><funding_grant_id>U01-HD-32632</funding_grant_id><funding_grant_id>U01-AI-35004</funding_grant_id><funding_grant_id>U01-AI-34993</funding_grant_id><funding_grant_id>U01-AI-34994</funding_grant_id><pubmed_authors>Estrella MM</pubmed_authors><pubmed_authors>Abraham A</pubmed_authors><pubmed_authors>Merenstein DJ</pubmed_authors><pubmed_authors>Anastos K</pubmed_authors><pubmed_authors>Astor BC</pubmed_authors><pubmed_authors>Parekh RS</pubmed_authors><pubmed_authors>Dehovitz JA</pubmed_authors><pubmed_authors>Cohen MH</pubmed_authors><pubmed_authors>Gange SJ</pubmed_authors><pubmed_authors>Szczech LA</pubmed_authors><pubmed_authors>Pearce CL</pubmed_authors><pubmed_authors>Tien PC</pubmed_authors></additional><is_claimable>false</is_claimable><name>The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.</name><description>BACKGROUND:In the early highly active antiretroviral therapy (HAART) era, kidney dysfunction was strongly associated with death among HIV-infected individuals. We re-examined this association in the later HAART period to determine whether chronic kidney disease remains a predictor of death after HAART initiation. METHODS:To evaluate the effect of kidney function at the time of HAART initiation on time to all-cause mortality, we evaluated 1415 HIV-infected women initiating HAART in the Women's Interagency HIV Study. Multivariable proportional hazards models with survival times calculated from HAART initiation to death were constructed; participants were censored at the time of the last available visit or December 31, 2006. RESULTS:Chronic kidney disease (estimated glomerular filtration rate less than 60 mL/min/1.73 m) at HAART initiation was associated with higher mortality risk adjusting for age, race, hepatitis C serostatus, AIDS history, and CD4 cell count (hazard ratio 2.23, 95% confidence interval: 1.45-3.43). Adjustment for hypertension and diabetes history attenuated this association (hazard ratio = 1.89, confidence interval: 0.94-3.80). Lower kidney function at HAART initiation was weakly associated with increased mortality risk in women with prior AIDS (hazard ratio = 1.09, confidence interval: 1.00-1.19, per 20% decrease in estimated glomerular filtration rate). CONCLUSIONS:Kidney function at HAART initiation remains an independent predictor of death in HIV-infected individuals, especially in those with a history of AIDS. Our study emphasizes the necessity of monitoring kidney function in this population. Additional studies are needed to determine mechanisms underlying the increased mortality risk associated with chronic kidney disease in HIV-infected persons.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Oct</publication><modification>2020-11-01T08:39:45Z</modification><creation>2019-03-27T00:47:14Z</creation></dates><accession>S-EPMC3243740</accession><cross_references><pubmed>20581688</pubmed><doi>10.1097/QAI.0b013e3181e674f4</doi><doi>10.1097/qai.0b013e3181e674f4</doi></cross_references></HashMap>